Genzyme launches EGFR assay

GENZ launched its EGFR Mutation Assay to identify patients likely to respond to targeted lung cancer drugs, including Iressa gefitinib from AstraZeneca (LSE:AZN; AZN) and Tarceva erlotinib from OSI (O...